ARKG vs EWZ
ARK Genomic Revolution ETF vs iShares MSCI Brazil ETF
ARKG$47.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
EWZ$32.42
iShares MSCI Brazil ETF
Brazilian large- and mid-cap equities.
Expense: 0.59%Yield: 4.51%
Quick take
- • EWZ has the lower expense ratio at 0.59% vs 0.75% for ARKG.
- • EWZ pays a higher dividend yield (4.51%).
Side-by-side metrics
| Metric | ARKG | EWZ |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.59% |
Dividend yield Trailing 12-month yield. | 0.00% | 4.51% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $9.62B |
YTD return | 66.55% | 3.62% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.92 |
P/E ratio | — | 10.36 |
Last price | $47.17 | $32.42 |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector breakdown · ARKG
Healthcare100.0%
EWZ top holdings
Top holdings · EWZ
| VALE3.SA | Vale SA | 8.65% |
| PETR3.SA | Petroleo Brasileiro SA Petrobras | 8.47% |
| NU | Nu Holdings Ltd Ordinary Shares Class A | 8.47% |
| WEGE3.SA | Weg SA | 3.42% |
| AXIA3.SA | Axia Energia | 2.99% |
| EMBJ3.SA | Embraer SA | 2.99% |
| B3SA3.SA | B3 SA - Brasil Bolsa Balcao | 2.98% |
Sector breakdown · EWZ
Consumer Cyclical1.5%
Basic Materials13.1%
Consumer Defensive4.5%
Communication Services1.9%
Financial Services31.8%
Utilities12.1%
Industrials11.7%
Energy21.4%
Healthcare2.0%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About EWZ
EWZ (iShares MSCI Brazil ETF) is Brazilian large- and mid-cap equities. Managed by iShares, the fund carries $9.6B in assets under management, an expense ratio of 0.59%, a dividend yield of 4.51%. Its largest holding is Vale SA (VALE3.SA), which represents 8.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.5%.